Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and Cisplatin
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John S Bomalaski, MD
Polaris Group
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
45 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chris O'Brien Lifehouse
Camperdown, New South Wales, Australia
- Tweed Hospital (nnsw Lhd)
Tweed Heads, New South Wales, Australia
- Princess Alexandria Hospital and Health Services
Woolloongabba, Queensland, Australia
- Southern Adelaide Local Health Network, Inc.
Bedford Park, South Australia, Australia
- Austin Health
Heidelberg, Victoria, Australia
- Sir Charles Gairdner Hospital
Perth, Western Australia, Australia
- Ss. Antonio E Biagio E Cesare Arrigo Hospital
Alessandria, AL, Italy
- Humanitas Gavazzeni
Bergamo, BG, Italy
- Ospedale Villa Scassi
Genova, GE, Italy
- Azienda Ospedaliera San Gerardo - Monza, Chirurgia Toracica
Monza, MB, Italy
- European Institute of Oncology
Milan, MI, Italy
- Fondazione Irccs Policlinico San Matteo
Pavia, PV, Italy
- Fondazione Irccs - Istituto Nazionale Dei Tumori Milano
Milan, Italy
- Azienda Ospedaliero Universitaria Di Parma
Parma, Italy
- Azienda Ospedaliero Universitaria Pisana
Pisa, Italy
- Chang Gung Medical Foundation Kaohsiung
Kaohsiung City, Taiwan
- Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan
- Taichung Veterans General Hospital
Taichung, Taiwan
- National Taiwan University Hospital
Taipei, Taiwan
- Taipei Veterans General Hospital
Taipei, Taiwan
- Chang Gung Memorial Foundation Linkou Branch
Taoyuan, Taiwan
- Addenbrooke'S Hospital
Cambridge, Cambridgeshire, United Kingdom
- Plymouth Hospitals (derriford Hospital)
Plymouth, Devon, United Kingdom
- Centre for Experimental Cancer Medicine (cecm)
London, England, United Kingdom
- Southampton General Hospital
Southampton, Hampshire, United Kingdom
- University Hospitals Leicester
Leicester, Leicestershire, United Kingdom
- Scunthorpe General Hospital
Scunthorpe, North Lincolnshire, United Kingdom
- Wansbeck General Hospital
Ashington, Northumberland, United Kingdom
- Oxford Cancer and Haematology Centre, the Churchill Hospital
Oxford, Oxfordshire, United Kingdom
- Velindre Cancer Centre
Cardiff, United Kingdom
- Edinburgh Cancer Centre
Edinburgh, United Kingdom
- Beatson West of Scotland Cancer Centre
Glasgow, United Kingdom
- St James'S University Hospital
Leeds, United Kingdom
- St Bartholomew'S Hospital
London, United Kingdom
- University Hospital of South Manchester
Manchester, United Kingdom
- Mayo Clinic
Phoenix, Arizona, United States
- Ucla Hematology & Oncology - Santa Monica
Los Angeles, California, United States
- University of California San Francisco Helen Diller Comprehensive Cancer Center
San Francisco, California, United States
- H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida, United States
- University of Chicago
Chicago, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Aug 2017
- Primary completion
- 15 Aug 2022
- Completion
- 15 Aug 2022
- Last update posted
- 4 Oct 2023
- Registered enrollment
- 249
- Registry id
- NCT02709512
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.